Bellino, Michele;
Silverio, Angelo;
Esposito, Luca;
Cancro, Francesco Paolo;
Ferruzzi, Germano Junior;
Di Maio, Marco;
Rispoli, Antonella;
Vassallo, Maria Giovanna;
Di Muro, Francesca Maria;
Galasso, Gennaro;
De Luca, Giuseppe
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions
Contributor:
Bellino, Michele;
Silverio, Angelo;
Esposito, Luca;
Cancro, Francesco Paolo;
Ferruzzi, Germano Junior;
Di Maio, Marco;
Rispoli, Antonella;
Vassallo, Maria Giovanna;
Di Muro, Francesca Maria;
Galasso, Gennaro;
De Luca, Giuseppe
Published:
MDPI AG, 2023
Published in:
Journal of Clinical Medicine, 12 (2023) 13, Seite 4550
Language:
English
DOI:
10.3390/jcm12134550
ISSN:
2077-0383
Origination:
Footnote:
Description:
Patients with acute coronary syndrome and multivessel disease experience several recurrent adverse events that lead to poor outcomes. Given the complexity of treating these patients, and the extremely high risk of long-term adverse events, the assessment of non-culprit lesions becomes crucial. Recently, two trials have shown a possible clinical benefit into treat non-culprit lesions using a fraction flow reserve (FFR)-guided approach, compared to culprit-lesion-only PCI. However, the most recent FLOW Evaluation to Guide Revascularization in Multivessel ST-elevation Myocardial Infarction (FLOWER-MI) trial did not show a benefit of the use of FFR-guided PCI compared to an angiography-guided approach. Otherwise, intracoronary imaging using optical coherence tomography (OCT), intravascular ultrasound (IVUS), or near-infrared spectroscopy (NIRS) could provide both quantitative and qualitative assessments of non-culprit lesions. Different studies have shown how the characterization of coronary lesions with intracoronary imaging could lead to clinical benefits in these peculiar group of patients. Moreover, non-invasive evaluations of NCLs have begun to take ground in this context, but more insights through adequately powered and designed studies are needed. The aim of this review is to outline the available techniques, both invasive and non-invasive, for the assessment of multivessel disease in patients with STEMI, and to provide a systematic guidance on the assessment and approach to these patients.